Guggenheim raises target for Elevance Health stock from USD 455.00 to USD 460.00

Published on 10/20/2026 at 11:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health reports third-quarter results on October 21, 2026 before the market opens. Elevance Health stock costs EUR 386.35 on October 20, 2026.

Report timing and analyst view

Guggenheim lifted its Elevance Health target from USD 455.00 to USD 460.00 on October 12, 2026.
Elevance Health will release third-quarter 2026 results on October 21, 2026 at 6:00 a.m. EDT.
Elevance Health stock trades at EUR 386.35 at 11:30 a.m. CEST at Lang & Schwarz on October 20, 2026.

Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte US2855211023 und Stethoskop — Elevance Health US2855211023 Flatlay mit Aktienzertifikat ISIN-Karte Stethoskop und medizinischen Utensilien auf Marmor, Illustration mit AI erstellt.

Elevance Health (ISIN US0367521038) is heading into its third-quarter report with Guggenheim raising its target from USD 455.00 to USD 460.00 on October 12, 2026, according to MarketScreener. The company is scheduled to publish its next results on October 21, 2026.

Guggenheim lifts its target

The October 12 analyst note kept a Buy rating while moving the target USD 5.00 higher. MarketScreener lists an average analyst target of USD 451.71 and 22 analysts in its consensus table, placing Guggenheim's USD 460.00 target USD 8.29 above that average.

The target change arrives as Elevance Health approaches a report that could clarify membership trends, medical costs and the outlook for the remainder of 2026. A recent preview from FinancialContent said analysts expected third-quarter revenue to decline 2.30 percent year over year.

What will the report test?

A preview carried by TranscriptDaily put consensus third-quarter revenue at USD 49.29 billion and expected earnings per share at USD 4.70. Those figures give investors a concrete test for the forecast of weaker year-over-year results.

Three dates frame the story

On October 21, 2025, Elevance Health reported third-quarter revenue of USD 50.10 billion, as reported by AlphaStreet. On July 15, 2026, the company released its second-quarter results, a date listed by 6ix, while FinancialContent cited latest-quarter revenue of USD 49.83 billion. On October 21, 2026, Elevance Health will release third-quarter results at 6:00 a.m. EDT.

When are the next dates?

The results release is scheduled for October 21, 2026 at 6:00 a.m. EDT, followed by management's conference call at 8:30 a.m. EDT, according to the company's Elevance Health release dated October 5, 2026.

Stock valuation before results

Elevance Health stock has a USD 274.84 to USD 436.24 52-week range based on October 16, 2026 figures. Its market capitalization was USD 92.9 billion on that date. The next report therefore arrives with the stock below its recent high while analyst targets remain above the latest US close.

Market price in euros

Elevance Health stock was trading at EUR 386.35 at Lang & Schwarz on October 20, 2026 at 11:30 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.